A substance being studied in the treatment of cancer. Urokinase plasminogen activator (uPA)-derived peptide A6 is a small piece of a protein called urokinase (an enzyme that dissolves blood clots or prevents them from forming). It is a type of antiangiogenesis agent and a type of antimetastatic agent. Also called A6.